BIM
Bogle Investment Management Portfolio holdings
AUM
$63M
This Quarter Return
+15.01%
1 Year Return
+52.22%
3 Year Return
+181.66%
5 Year Return
+959.74%
10 Year Return
–
AUM
$1.45B
AUM Growth
+$1.45B
(+4.5%)
Cap. Flow
+$14.9M
Cap. Flow
% of AUM
1.03%
Top 10 Holdings %
Top 10 Hldgs %
12.09%
Holding
481
New
136
Increased
88
Reduced
93
Closed
159
Top Buys
| 1 |
NCR Voyix
VYX
|
$13.8M |
| 2 |
Stellantis
STLA
|
$13.2M |
| 3 |
Grand Canyon Education
LOPE
|
$13.1M |
| 4 |
Ryanair
RYAAY
|
$13M |
| 5 |
STMicroelectronics
STM
|
$13M |
Top Sells
| 1 |
PVH
PVH
|
$18.2M |
| 2 |
Trinseo
TSE
|
$18.1M |
| 3 |
Silicon Motion
SIMO
|
$17.6M |
| 4 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$17.5M |
| 5 |
Coeur Mining
CDE
|
$17.1M |
Sector Composition
| 1 | Healthcare | 19.95% |
| 2 | Technology | 17.14% |
| 3 | Industrials | 14.22% |
| 4 | Consumer Discretionary | 12.77% |
| 5 | Materials | 7.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
AAR Corp
AIR
$2.72B
| – | – |
-26,956
| Closed | -$844K |
|
402
Assurant
AIZ
$10.8B
| – | – |
-13,501
| Closed | -$1.25M |
|
403
Ambac
AMBC
$423M
| – | – |
-70,396
| Closed | -$1.29M |
|
404
Anika Therapeutics
ANIK
$130M
| – | – |
-22,629
| Closed | -$1.08M |
|
405
ANI Pharmaceuticals
ANIP
$2.06B
| – | – |
-55,705
| Closed | -$3.7M |
|
406
Accuray
ARAY
$165M
| – | – |
-66,577
| Closed | -$424K |
|
407
Avanos Medical
AVNS
$573M
| – | – |
-221,625
| Closed | -$7.68M |
|
408
Avery Dennison
AVY
$13B
| – | – |
-13,800
| Closed | -$1.07M |
|
409
Axalta
AXTA
$6.67B
| – | – |
-40,247
| Closed | -$1.14M |
|
410
Biogen
BIIB
$20.8B
| – | – |
-35,011
| Closed | -$11M |
|
411
Bankunited
BKU
$2.92B
| – | – |
-8,496
| Closed | -$256K |
|
412
Box
BOX
$4.69B
| – | – |
-102,160
| Closed | -$1.61M |
|
|
413
Coeur Mining
CDE
$8.98B
| – | – |
-1,444,241
| Closed | -$17.1M |
|
414
CEVA Inc
CEVA
$520M
| – | – |
-40,859
| Closed | -$1.43M |
|
415
Churchill Downs
CHDN
$7.12B
| – | – |
-8,906
| Closed | -$1.3M |
|
416
Celldex Therapeutics
CLDX
$1.57B
| – | – |
-996,178
| Closed | -$4.02M |
|
417
Clearwater Paper
CLW
$346M
| – | – |
-69,025
| Closed | -$4.46M |
|
418
Ennis
EBF
$468M
| – | – |
-12,587
| Closed | -$212K |
|
419
Emergent Biosolutions
EBS
$418M
| – | – |
-162,870
| Closed | -$5.14M |
|
420
New Oriental
EDU
$7.98B
| – | – |
-158,168
| Closed | -$7.33M |
|
421
Copel
ELP
$6.61B
| – | – |
-271,028
| Closed | -$2.81M |
|
422
Enanta Pharmaceuticals
ENTA
$189M
| – | – |
-13,832
| Closed | -$368K |
|
423
Energy Recovery
ERII
$750M
| – | – |
-475,783
| Closed | -$7.6M |
|
424
Esperion Therapeutics
ESPR
$490M
| – | – |
-74,961
| Closed | -$1.04M |
|
425
First Hawaiian
FHB
$3.23B
| – | – |
-9,745
| Closed | -$261K |
|